Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HCFA Support Of CREST Study Could By Aided By White House Directive

This article was originally published in The Gray Sheet

Executive Summary

President Clinton's June 7 executive memorandum aimed at increasing the participation of Medicare beneficiaries in clinical trials could facilitate federal reimbursement for studies of currently non-covered procedures, such as the CREST carotid stent trial.

You may also be interested in...



Medicare clinical trial coverage

National coverage decision addressing routine care costs in clinical trials could be issued by the Health Care Financing Administration as early as the week of July 24. Included will be definitions of what the agency considers "routine" care costs and which clinical trials qualify for such coverage, staffers note. Following a comment period, HCFA intends to make the decision effective by Sept. 15. Implementation would fulfill one part of a June 7 Presidential executive memo which also directs HCFA to explore the possibility of expanding Medicare coverage to certain experimental procedures (1"The Gray Sheet" June 12, p. 5)

Medicare clinical trial coverage

National coverage decision addressing routine care costs in clinical trials could be issued by the Health Care Financing Administration as early as the week of July 24. Included will be definitions of what the agency considers "routine" care costs and which clinical trials qualify for such coverage, staffers note. Following a comment period, HCFA intends to make the decision effective by Sept. 15. Implementation would fulfill one part of a June 7 Presidential executive memo which also directs HCFA to explore the possibility of expanding Medicare coverage to certain experimental procedures (1"The Gray Sheet" June 12, p. 5)

Med/Surg Panel Ratification Signals MCAC EC Confidence In Interim Process

Ratification by the Medicare Coverage Advisory Committee's executive committee of the Medical and Surgical Procedures Panel's April 13 proceedings signals the body's confidence in the effectiveness of their interim operating procedures to guide panel deliberations.

Related Content

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel